10. okt. 2024 ... (Teva USA) and Teva Neuroscience Inc. (collectively, Teva) have agreed to pay $450 million to resolve two matters that allege Teva violated the ...

10. okt. 2024 ... Teva to pay $450 million to resolve US kickback, price-fixing cases · Suggested Topics: · Litigation · Lawsuits · Health · Regulatory Oversight

18. mars 2025 ... In its original complaint, which it amended last month, Teva claims the price negotiation program is a “fiction” and “upsets the delicate ...

On June 2, 2022, BFA secured final approval of the $420 million settlement after five years of hard-fought litigation.

16. jan. 2025 ... Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price negotiation program.

12. okt. 2024 ... BOSTON — Teva Pharmaceutical Industries Ltd. has agreed to pay $450 million to resolve allegations it used charities that help cover ...

11. des. 2024 ... Grünenthal has entered into a settlement agreement with Teva Pharmaceuticals, Inc. (Teva) resolving their patent litigation in the US.

The settlement will create a $420 million cash fund, plus earned interest, for the benefit of eligible Settlement Class Members.

9. sep. 2024 ... Mayor Brandon M. Scott and the City of Baltimore announced they have reached an $80 million settlement with Teva Pharmaceuticals to resolve ...

10. feb. 2025 ... Axsome has resolved a patent infringement lawsuit against Teva, which will keep Teva's generic version of Auvelity off the market until at ...